封面
市場調查報告書
商品編碼
1465542

血液透析設備市場 - 副產品(血液透析機、消耗品)、最終用途(醫院、透析中心、家庭護理設施) - 全球預測,2024 年 - 2032 年

Hemodialysis Equipment Market - By Product (Hemodialysis Machines, Consumables), End-use (Hospitals, Dialysis Centers, Homecare Settings) - Global Forecast, 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 184 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於高血壓、糖尿病和人口老化等因素導致 ESRD(末期腎病)病例增加,預計血液透析設備市場從 2024 年到 2032 年的複合年成長率將達到 6.4%。根據國際腎臟病學會的數據,到 2023 年,全球約有 8.5 億人患有慢性腎臟病。此外,技術的進步,例如攜帶式和家用血液透析機的開發,提高了患者的便利性和可及性。

此外,人們越來越認知到早期發現和治療腎臟疾病的好處,加上醫療支出不斷增加,正在促進血液透析設備的使用。醫療保健提供者擴大投資於創新解決方案,以滿足對腎臟替代療法不斷成長的需求。此外,主要參與者在產品開發和地理擴張方面的策略合作和夥伴關係將促進市場成長。

血液透析設備產業根據產品、最終用途和地區進行分類

從產品來看,血液透析機領域的市場價值在2024年至2032年間將錄得6.5%的成長率。 。此外,旨在改善透析服務機會的優惠報銷政策和措施正在刺激血液透析機的使用,特別是在新興經濟體。

由於腎臟疾病盛行率不斷上升,預計到 2032 年,透析中心最終用途領域的血液透析設備市場複合年成長率將達到 6.2%。透析中心需要一系列血液透析設備,包括機器、透析器和水處理系統,以便為患者提供高品質的腎臟替代療法。此外,數位監控系統和遠端患者管理解決方案的整合正在提高透析中心運作的效率和有效性,進一步推動對現代血液透析設備的需求。

由於人口迅速老化,亞太地區血液透析設備產業到 2032 年將以 6.9% 的複合年成長率實現顯著成長。不斷成長的醫療保健支出,加上政府為提高腎臟替代治療的可及性而採取的舉措,正在推動中國、印度和日本等國家對血液透析設備的需求。此外,血液透析機的技術進步有助於滿足特定需求,例如經濟高效和緊湊的設計。此外,國際和本地參與者之間開發創新解決方案和擴大分銷網路的策略合作將進一步推動區域市場的成長。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 腎臟疾病盛行率增加
      • 增加研發投入
      • 血液透析設備的技術進步
      • 老年人口基數不斷增加
    • 產業陷阱與挑戰
      • 嚴格的監管場景
      • 設備成本高
  • 成長潛力分析
  • 監管環境
  • 技術景觀
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章:市場估計與預測:按產品分類,2018 年 - 2032 年

  • 主要趨勢
  • 血液透析機
    • 中心血液透析機
    • 家用血液透析機
  • 耗材
    • 透析器
    • 透析液
    • 接入產品
    • 其他消耗品

第 6 章:市場估計與預測:依最終用途,2018 - 2032 年

  • 主要趨勢
  • 醫院
  • 透析中心
  • 家庭護理設置
  • 其他最終用戶

第 7 章:市場估計與預測:按地區分類,2018 年 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 8 章:公司簡介

  • Asahi Kasei Corporation.
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Diaverum Holding AB
  • DaVita Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • Nipro Corporation
  • Nikkiso Co., Ltd
  • Rockwell Medical Technologies Inc.
  • Toray Industries, Inc.
簡介目錄
Product Code: 8038

Hemodialysis equipment market is estimated to record 6.4% CAGR from 2024 to 2032, driven by the rise in ESRD (end-stage renal disease) cases, attributed to factors, such as hypertension, diabetes, and aging population. As per the International Society of Nephrology, in 2023, around 850 million people suffered from chronic kidney diseases globally. Moreover, advancements in technology, such as the development of portable and home hemodialysis machines are enhancing patient convenience and accessibility.

Furthermore, the growing awareness about the benefits of early detection and treatment of kidney diseases coupled with rising healthcare expenditure are fostering the use of hemodialysis equipment. Healthcare providers are increasingly investing in innovative solutions to cater to the escalating demand for renal replacement therapies. Additionally, strategic collaborations and partnerships among key players for product developments and geographic expansion will bolster the market growth.

The hemodialysis equipment industry is classified on the basis of product, end-use and region

Based on product, the market value from the hemodialysis machines segment will record a 6.5% growth rate between 2024 and 2032. This is favored by technological advancements in the machines, such as the integration of touchscreen interfaces, improved monitoring capabilities, and enhanced automation features. Furthermore, favorable reimbursement policies and initiatives aimed at improving access to dialysis services are stimulating the uptake of hemodialysis machines, particularly in emerging economies.

Hemodialysis equipment market from the dialysis centers end-use segment is expected to witness a 6.2% CAGR till 2032, backed by the increasing prevalence of kidney diseases. Dialysis centers require a range of hemodialysis equipment, including machines, dialyzers, and water treatment systems, to deliver high-quality renal replacement therapy to patients. Additionally, the integration of digital monitoring systems and remote patient management solutions are enhancing the efficiency and effectiveness of dialysis center operations, further fueling the demand for modern hemodialysis equipment.

Asia Pacific hemodialysis equipment industry will record notable growth at 6.9% CAGR through 2032, attributed to the rapidly aging population. Rising healthcare expenditure, coupled with government initiatives to enhance access to renal replacement therapy, is fueling the demand for hemodialysis equipment in countries like China, India, and Japan. Furthermore, technological advancements in hemodialysis machines are helping to meet specific needs, such as cost-effective and compact designs. Additionally, strategic collaborations between international and local players to develop innovative solutions and expand distribution networks will further boost the regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast calculations
  • 1.5 Data sources
    • 1.5.1 Primary
    • 1.5.2 Secondary
      • 1.5.2.1 Paid sources
      • 1.5.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of kidney diseases
      • 3.2.1.2 Increased R&D investments
      • 3.2.1.3 Technological advancements in hemodialysis equipment
      • 3.2.1.4 Growing geriatric population base
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Stringent regulatory scenario
      • 3.2.2.2 High cost of devices
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Hemodialysis machines
    • 5.2.1 In-center hemodialysis machine
    • 5.2.2 Home-based hemodialysis machine
  • 5.3 Consumables
    • 5.3.1 Dialyzers
    • 5.3.2 Dialysate
    • 5.3.3 Access products
    • 5.3.4 Other consumables

Chapter 6 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Hospitals
  • 6.3 Dialysis centers
  • 6.4 Homecare settings
  • 6.5 Other end-users

Chapter 7 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East and Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 South Africa
    • 7.6.3 UAE
    • 7.6.4 Rest of Middle East and Africa

Chapter 8 Company Profiles

  • 8.1 Asahi Kasei Corporation.
  • 8.2 Baxter International Inc.
  • 8.3 B. Braun Melsungen AG
  • 8.4 Diaverum Holding AB
  • 8.5 DaVita Inc.
  • 8.6 Fresenius Medical Care AG & Co. KGaA
  • 8.7 Nipro Corporation
  • 8.8 Nikkiso Co., Ltd
  • 8.9 Rockwell Medical Technologies Inc.
  • 8.10 Toray Industries, Inc.